Skip to content

Biz News Today

Business News – Direct Source News

  • Home
  • Business News Videos
    • International/National News Videos
  • Directory
  • Links PRs
  • REITS
  • About
  • Contact
    • Sitemap

Agenus and Bristol Myers Squibb Announce Exclusive Global License for Agenus’ Anti-TIGIT Bispecific Antibody Program

  • Home
  • 2021
  • May
  • 18
  • Agenus and Bristol Myers Squibb Announce Exclusive Global License for Agenus’ Anti-TIGIT Bispecific Antibody Program

Original Source

On May 18, 2021

Post navigation

Previous PostQorvo to Present at the J.P. Morgan Global Technology, Media and Communications Conference
Next PostDollar General Continues COVID-19 Proactive and Preventative Measures

Related Post

May 27, 2022
  • Business News

U.S. Food and Drug Administration Approves Two Opdivo® (nivolumab)-Based Regimens as First-Line Treatments for Unresectable Advanced or Metastatic Esophageal Squamous Cell Carcinoma

May 27, 2022
  • Business News

NVIDIA Recommends Stockholders Reject ‘Mini-Tender’ Offer by Tutanota LLC

May 27, 2022
  • Business News

Quanta Services Announces Quarterly Cash Dividend

Copyright © All right reserved
Newslist Created By Rise Themes

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home/biznews/public_html/wp-includes/functions.php on line 5219